Congratulations to TH MEDICAL-B (Stock Code: 2697.HK) on the Successful IPO on the Main Board of the HKEX!

CR SWCS Team is honoured to serve as the Joint Company Secretary of TH MEDICAL-B, committed to ensuring governance, compliance, and sustained growth.

COMPANY PROFILE

TH MEDICAL-B was founded in 2018 and is a national-level "Little Giant" enterprise with artificial intelligence and robotic control as its core technologies, specializing in the R&D and industrialization of intelligent robots for soft tissue puncture diagnosis and treatment and organ repair. With puncture and ablation surgical robots as our core products, we have built a full-stack technological capability covering puncture biopsy, surgical positioning, precision ablation, particle implantation and other diagnostic and therapeutic applications for thoracic and abdominal visceral organs. Our products and services have been adopted in over 100 hospitals across China, with more than 7,200 procedures completed cumulatively, empowering clinical practices to achieve precise, safe and efficient minimally invasive diagnosis and treatment.

Source: http://www.truehealth.cn/